Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma	Metastatic NUT Carcinoma; Unresectable NUT Carcinoma	Recruiting	Phase 2	2026-08-18		NCT07050186

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015
Northwestern University	381

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Northwestern University	Chicago	United States	727

Clinical trials